Nathan Charles, the former Australian rugby union international who defied a childhood diagnosis of cystic fibrosis to build a career in one of the most physically demanding sports, has recently been diagnosed with motor neurone disease (MND). The 37‑year‑old, who earned his first Wallabies cap in 2014 and went on to collect four test appearances—including a memorable 12‑12 stalemate against the All Blacks—made the announcement earlier this week during a conversation with ex‑Wallaby lock and current commentator Justin Harrison on Stan Sport.
Charles, who hung up his boots in 2018, explained that the road to diagnosis was long and fraught with uncertainty. "For a long period there I just didn't know what it was," he said.
"I've had many tests and seen many doctors, but we just weren't getting any answers. My health just kept declining." It was only in the past few weeks that specialists were able to confirm that he is living with motor neurone disease, a progressive group of neurological disorders that attack the motor neurons responsible for controlling voluntary muscle movement. The most prevalent form of MND is amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease.
The former hooker described the news as "extremely challenging and overwhelming," acknowledging that there is currently no cure and that the condition inevitably leads to a gradual loss of physical function. "Your physicality, your body deteriorates and, yeah, your life cuts short," he said, underscoring the stark reality faced by those diagnosed with the disease. Charles' rugby journey began in Perth, where he played Super Rugby for the Western Force before moving to the Melbourne Rebels.
He later took his talents overseas, turning out for English clubs Gloucester, Bath and Wasps. After retiring from professional play, he transitioned into administration, serving as chief executive of Rugby Western Australia and taking an active role with the Sydney University Rugby Club.
His personal story is marked by an extraordinary battle against cystic fibrosis, a genetic disorder that primarily impairs the lungs and digestive system. Charles was diagnosed with CF when he was just three months old and was warned that he might not survive beyond his tenth birthday.
Defying those grim predictions, he not only reached adulthood but also excelled at the elite level of rugby, becoming a living testament to the power of determination. "I am constantly pushing the boundaries and am living proof that anything is possible," he wrote on his website while raising awareness for cystic fibrosis.
"It is my personal mission to truly exceed the life expectancy of 37 years [which is the life expectancy of people with CF]." Now, faced with a second, unrelated health challenge, Charles reflected on the irony of his situation. "I was born with a life‑threatening illness. I've given that a red‑hot crack. Now this other thing comes along," he said.
"I find it quite ironic that something else will strike me down rather than what I've been dealing with for my whole life." Charles is not alone among rugby players in confronting MND. Former England captain and 2003 World Cup winner Lewis Moody received the same diagnosis last year. In recent years, the sport has also lost several high‑profile figures to the disease, including former Leeds Rhinos legend Rob Burrow and Scottish union great Doddie Weir, both of whom became prominent advocates for MND research before their deaths.
The Australian national side, which is currently gearing up for the upcoming Bledisloe Cup series against New Zealand, expressed solidarity with their former teammate on social media. Wallabies captain Harry Wilson posted a heartfelt message, stating, "We know you have a tough time ahead, but we're with you every step of the way." The team’s support highlights the close‑knit community that exists within Australian rugby, where former players are often regarded as part of an extended family.
While there is no cure for motor neurone disease at present, research efforts continue worldwide, with organizations such as the Motor Neurone Disease Association and ALS Association funding studies aimed at understanding the underlying mechanisms and developing potential therapies. High‑profile cases like Charles' help draw public attention to the cause, potentially accelerating fundraising and scientific progress. In the meantime, Charles has pledged to use his platform to raise awareness for both cystic fibrosis and MND, hoping that his story will inspire others facing similar battles.
He remains actively involved in rugby administration and community initiatives, demonstrating that even as his body confronts new limitations, his commitment to the sport and to advocacy remains unwavering. As the Wallabies prepare for their upcoming tests, the broader rugby community watches closely, offering both moral support and a reminder of the resilience that defines many of its former heroes.
Charles' journey—from a baby told he would not survive past ten, to an international athlete, to a vocal advocate for two serious illnesses—continues to inspire and underscores the profound impact that personal perseverance can have on raising awareness for life‑threatening conditions.